ArticleThe oncologist2022

Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.

J Connor Wells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.